preconditioning prior to non-myeloablative matched sibling donor hsct in patients with scd
Published 5 days ago • 46 plays • Length 1:01Download video MP4
Download video MP3
Similar videos
-
0:46
prolonging survival in patients with aml ineligible for intensive chemotherapy
-
1:19
barriers to accessing reni-cel for the treatment of scd
-
2:39
non t-cell depleted haploidentical vs. matched sibling donor hsct in adult all in remission
-
3:34
clofarabine preconditioning followed by allogeneic transplantation with tbi & ptcy for r/r aml
-
1:45
a phase i/ii trial of glofitamab monotherapy in r/r mcl
-
2:53
autohct in dlbcl in the car-t era
-
4:31
labmt: impact of treatment prior to allogenic hct in mds
-
9:42
bone marrow transplant with 50% matching donor successful
-
35:31
machine learning and artificial intelligence in hematology
-
20:26
3mensio ct pre-case planning: redo-tavr with prior sapien 3 (2 of 2)
-
1:56
incorporating novel agents for myelofibrosis in the pre- and post-transplant settings
-
1:03
using bispecific antibodies instead of chemotherapy to reach pre-transplant remission in b-all
-
3:33
the growing role of machine learning in hematological oncology
-
2:30
systematic review comparing allogeneic transplant patients with non-transplant patients in mf
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
3:46
the impact of cytogenetic risk on outcomes of haploidentical transplantation in r/r aml
-
1:47
treatment options for penta-refractory multiple myeloma
-
1:44
imerge update: continuous transfusion independence & disease modification with imetelstat in lr-mds
-
4:29
smoldering myeloma: monitoring patients and deciding when to treat
-
2:38
zuma-1 & scholar-1: comparison of outcomes in refractory dlbcl
-
3:37
2020 uk aml trials update